GEN Exclusives

More »

GEN News Highlights

Back to Item »

Researchers Claim Blocking Cdk1 Makes Wild-Type BRCA1 Cancers Susceptible to PARP Inhibition

Studies demonstrate that activity of BRCA1 in homologous recombination relies on cyclin-dependent kinase.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Alzheimer's Therapies

Do you think an effective treatment for Alzheimer’s will be found within the next 10–15 years?